UVS Hospitality and Services Appoints Prathima Madineni as Managing Director for Five-Year Term
UVS Hospitality and Services Limited appointed Mrs. Prathima Madineni as Additional Director and Managing Director for a five-year term from January 30, 2026 to January 29, 2031, subject to shareholder approval. The appointment was approved by the Board of Directors based on Nomination and Remuneration Committee recommendations. Mrs. Madineni brings over two decades of pharmaceutical marketing experience with expertise in portfolio growth, strategic marketing, and brand leadership across therapeutic areas including dermatology, gynecology, and pain management.

*this image is generated using AI for illustrative purposes only.
UVS Hospitality and Services Limited has announced key leadership changes with the appointment of Mrs. Prathima Madineni as Managing Director for a five-year term. The Board of Directors approved the appointment during their meeting held on January 30, 2026, based on recommendations from the Nomination and Remuneration Committee.
Board Appointment Details
The company's Board of Directors has made two significant appointments for Mrs. Prathima Madineni (DIN: 06365444):
| Position: | Details |
|---|---|
| Additional Director: | Executive category, effective January 30, 2026 |
| Managing Director: | Five-year term from January 30, 2026 to January 29, 2031 |
| Approval Status: | Subject to shareholder approval |
| Board Meeting Duration: | 11:00 a.m. to 11:10 a.m. on January 30, 2026 |
The company confirmed that Mrs. Madineni is not debarred from holding the office of director by virtue of any SEBI order or any other authority, in accordance with the stock exchange circular dated June 20, 2018.
Professional Background
Mrs. Prathima Madineni brings extensive pharmaceutical industry experience to her new role. Her professional profile highlights include:
- Over two decades of pharmaceutical marketing leadership experience
- Expertise in portfolio growth and strategic marketing initiatives
- Strong track record in team leadership and brand development
- Experience with differentiated brand go-to-market launches across leading Indian pharmaceutical companies
- Specialization in acute and sub-chronic therapies including dermatology, gynecology, gastrointestinal, pain management, and nutrition
- Proven ability to deliver revenue growth, market-share gains, and brand leadership
- Early adoption of social and digital platforms for patient engagement and physician activation
Regulatory Compliance
The appointment has been made in full compliance with the provisions of the Companies Act, 2013 and follows proper corporate governance protocols. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Compliance Parameter: | Status |
|---|---|
| Companies Act 2013: | Compliant |
| SEBI Listing Regulations: | Regulation 30 disclosure made |
| Debarment Status: | Not debarred by SEBI or other authorities |
| Other Directorships: | None in listed entities |
The appointment is subject to approval by the company's shareholders and represents a strategic move to strengthen the leadership team with experienced pharmaceutical industry expertise.
Historical Stock Returns for UVS Hospitality And Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.79% | -4.75% | -10.65% | -16.56% | -37.90% | +223.92% |






























